Coefficient of variation, signal-to-noise ratio, and effects of normalization in validation of biomarkers from NMR-based metabonomics studies
A primary goal of metabonomics research is biomarker discovery for human diseases based on differences in metabolic profiles between healthy and diseased patient populations. One of the most significant challenges in biomarker discovery is validation, which implicitly depends on the coefficient of variation (CV) associated with the measurement technique. This paper investigates how the CV of metabolite resonances measured by nuclear magnetic resonance spectroscopy (NMR) depends on signal-to-noise ratio (SNR) and normalization method. CVs were calculated for NMR resonance peaks in a series of NMR spectra of five synthetic urine samples collected over an eight-month period. An inverse correlation was detected between SNR and CV for all normalization methods. Small peaks with SNR   150, which typically had smaller CVs (5-10%). The inverse relationship between CV and SNR roughly obeyed a log(10) dependence. Quotient normalization (QN) tended to produce smaller CVs for smaller peaks, but larger CVs for the strongest peaks in the data, compared to no normalization, normalization to total intensity (NTI) or normalization to an internal standard (NIS). Consequently, quotient normalization appears optimal for validating low concentration metabolites. NTI or NIS appear superior to QN for samples that have very small variation in total signal intensity. While the inverse relationship between CV and log(10)(SNR) did not strictly hold for all metabolites, weaker concentration metabolites will likely require more rigorous validation as potential biomarkers since they tend to have poorer reproducibility. (C) 2013 Elsevier B.V. All rights reserved.
coefficient of variation metabonomics nuclear magnetic resonance metabolomics biomarker validation